SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease
Stefania Colarusso(IRBM Science Park), Jesus M. Ontoria(IRBM Science Park), Francesca Pavone(IRBM Science Park), Antonino Missineo(IRBM Science Park), Giacomo Paonessa(Fondazione Roma), Jérôme Amaudrut(IRBM Science Park), Federica Ferrigno(IRBM Science Park), Elisa Beghetto(IRBM Science Park), Christian Montalbetti(IRBM Science Park), Immacolata Conte(IRBM Science Park), Simona Ponzi(IRBM Science Park), Elisabetta Bianchi(IRBM Science Park), Licia Tomei(IRBM Science Park), Alberto Bresciani(University of Bergamo), Luigi Abate(IRBM Science Park), Carlo Toniatti(The University of Texas MD Anderson Cancer Center)
Cited by 11
Related Papers
Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
|Science Signaling|2017|307
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
|Cancer Research|2015|275
Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region
|Nucleic Acids Research|1986|246
Structural analysis of the X‐linked gene encoding human glucose 6‐phosphate dehydrogenase.
|The EMBO Journal|1986|229
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156